Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post‐discharge period

Hospitalization for acute heart failure (HF) is associated with a substantial morbidity burden and with associated healthcare costs and an increased mortality risk. However, few if any major medical innovations have been witnessed in this area in recent times. Levosimendan is a first‐in‐class calciu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pölzl, Gerhard, Allipour Birgani, Shadab, Comín‐Colet, Josep, Delgado, Juan F., Fedele, Francesco, García‐Gonzáles, Martín Jesús, Gustafsson, Finn, Masip, Josep, Papp, Zoltán, Störk, Stefan, Ulmer, Hanno, Vrtovec, Bojan, Wikström, Gerhard, Altenberger, Johann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Study Designs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351894/
https://www.ncbi.nlm.nih.gov/pubmed/30378288
http://dx.doi.org/10.1002/ehf2.12366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351894/
https://www.ncbi.nlm.nih.gov/pubmed/30378288
http://dx.doi.org/10.1002/ehf2.12366

Ejemplares similares